A US$115 Billion AI Takeover Has Exposed a Price Gap. Approval and Share-Price Risks Remain.

Effect on you

Two technology companies agreed to combine in a major AI-infrastructure transaction. Their shares subsequently fell sharply, rather than holding their pre-announcement prices.

That contradiction deserves attention.

What changed

On 2 November 2026, Marvell Technology (NASDAQ: MRVL) announced an agreement to acquire Lumentum (NASDAQ: LITE) in an all-share transaction initially valued at approximately US$115 billion, including debt.

Marvell develops chips that help computers communicate. Lumentum manufactures optical equipment that moves information using light.

As AI data centres become larger, thousands of processors must exchange information quickly. Electricity and processing power are not enough if information gets stuck between machines.

The companies want to combine their technologies, manufacturing expertise and customers.

But the most interesting finding is in the financial terms.

For every Lumentum share, investors are supposed to receive 4.5 Marvell shares when the merger closes.

At the US regular market close on 6 November, MRVL was US$141.20 and LITE was US$538.59. At those prices, 4.5 MRVL shares were worth US$635.40, a theoretical gap of US$96.81 per Lumentum share.

Calculation from the 6 November 2026 closing prices. This is not guaranteed profit or an executable arbitrage return.

A Lumentum share was trading roughly 15.2% below the value of the Marvell shares it would receive at those prices.

Why would that happen?

Because the takeover is not expected to close until the first half of 2028. Both groups of shareholders must approve it, regulators must agree, and the companies must keep operating successfully.

The agreement includes conditional termination fees of US$5.8 billion for Marvell and US$2.9 billion for Lumentum in specified change-of-recommendation or alternative-transaction circumstances, and a separate conditional US$3.2 billion Marvell regulatory termination fee. The contractual triggers differ. These are corporate payments, not compensation promised to ordinary shareholders.

The exchange ratio is fixed, but its dollar value is not. An unhedged Lumentum holder can lose money if Marvell shares fall, even if the transaction closes.

The discounted Lumentum price is therefore not proof that investors have overlooked free money. It is evidence that they are pricing uncertainty, time and the possibility of failure.

And another development makes the situation more interesting.

On 2 November, Lumentum announced that it had secured a second major optical technology customer win, supported by purchase commitments exceeding US$5 billion.

These commitments relate to Lumentum's optical products, not completion of the Marvell merger. They represent real commercial evidence beyond the acquisition announcement, although delivery dates, customer names, cancellation terms and received cash were not fully disclosed.

Lumentum's latest quarterly revenue reached US$1.263 billion, compared with US$534 million a year earlier. Its reported operating margin was 28.5%.

Marvell's latest fully reported quarterly revenue was US$2.739 billion, up 37% annually, with US$308 million in net income.

Meanwhile, competitor Coherent Corp. (NYSE: COHR) reported US$2.37 billion in quarterly revenue on 4 November, up approximately 50% annually.

This is not an industry waiting for its first customer. Companies are already selling substantial amounts of equipment.

The connection we found

The signed merger and the observed share-price discount connect a conditional financial transaction with a possible change in customer sourcing. A larger combined supplier could encourage buyers to assess alternatives, but incremental rival orders are unverified. Our database suggests three opportunities.

How it could work

Opportunity 1: Investigating the merger-price gap. Professional investors can compare Lumentum's share price with the value of 4.5 Marvell shares, then examine approval risks, financing costs and the chance of the merger collapsing. A properly hedged position would normally involve buying Lumentum and selling short the agreed number of Marvell shares. Borrowing and short-selling can create substantial losses and are not suitable as a simple retail-income strategy.

Opportunity 2: Alternative suppliers and manufacturing partners may gain work. Coherent is an optical-product supplier to research if buyers seek an alternative. Fabrinet (NYSE: FN) provides packaging and manufacturing services to equipment makers, so its exposure depends on which customers and programmes win work. It is not an interchangeable optical-product rival. Neither company's incremental orders attributable to merger concerns have been verified.

Opportunity 3: Optical testing and manufacturing support. Qualified engineering firms could help equipment buyers test products from different suppliers for performance, reliability and compatibility. The strongest opportunity would be a paid assessment from a customer already comparing vendors, not speculative purchases of optical inventory.

What could happen next

The timing is important.

Marvell and Lumentum will remain separate businesses until closing. Buyers have time to evaluate alternatives, while investors have time to examine whether the deal's proposed benefits justify the price.

We think the overlooked issue is not simply that AI needs faster connections. OnTheRice has already researched optical connections.

The new question is whether the creation of a larger combined optical supplier could change customer purchasing decisions before the merger legally takes place.

Early warning: Watch whether Lumentum's US$5 billion-plus commitments become actual deliveries, whether Coherent or Fabrinet reports customer wins linked to supplier diversification, and whether the merger-value gap narrows without a corresponding deterioration in business results.

What would prove us wrong? If customers have no problem relying on the combined company, competing suppliers do not win extra orders, or the merger fails because of regulation or operational problems, the expected commercial advantage could disappear.

Original sources and timestamps: Marvell–Lumentum SEC transaction announcement, 2 November 2026; Merger agreement and termination provisions, filed 2 November; Lumentum fiscal Q1 2027 results, released 2 November; Marvell financial results, 27 August 2026; Coherent results, 4 November; Fabrinet results, 2 November; MRVL price history, 6 November at 16:00 US Eastern; LITE closing price, 6 November at 16:00 US Eastern. The filings document the agreement; secondary share-market data establish the observed gap. Customer diversification remains a forecast. Exact original publication clocks are unavailable unless stated. The Coherent release could not be directly opened in this verification; its publicly indexed company release and filing support the quoted quarterly figures.

• [S1]
• [S2]
• [S3]
• [S4]
• [S5]
• [S6]
• [S7]
• [S8]
• [S9]

• [S10]
• [S11]

Twenty-layer intelligence analysis Layer 1. Money movement: US$115bn announced enterprise deal value; more than US$5bn in Lumentum purchase commitments. Neither represents US$115bn cash changing hands today.

Layer 2. Early purchasing: Lumentum reported its second major optical customer win. Exact delivery schedules and receipts were not disclosed.

Layer 3. Supply bottlenecks: Fast optical connections require specialised lasers, packaging and testing. The proposed merger would combine capabilities but does not prove individual supplier shortages.

Layer 4. Hidden beneficiaries: Coherent is an optical-product competitor. Fabrinet supplies manufacturing services to equipment makers, with uncertain exposure to their programme wins or losses. Independent testing and manufacturing specialists are possible beneficiaries, subject to customer qualification.

Layer 5. Company finances: Marvell Q2 revenue US$2.739bn, GAAP gross margin 53.1%, net income US$308m. Lumentum Q1 revenue US$1.263bn, operating margin 28.5%, cash and short-term investments US$2.0bn. Coherent Q1 revenue US$2.37bn, gross margin 39.1%. Current market values are approximately US$124bn for MRVL, US$48.8bn for LITE and US$38bn for COHR based on 6 November data. Complete customer concentration and merger-specific earnings remain unverified.

Layer 6. Unit economics: The US$96.81 per-share theoretical merger gap is before borrowing charges, dividends, financing, taxes and execution costs. For equipment services, actual labour hours, customer prices and equipment costs are needed before calculating profit or payback.

Layer 7. Insider activity: The signed agreement and board approvals are documented. Shareholder votes remain closing conditions. No incremental insider share purchases establishing conviction were verified.

Layer 8. Hiring changes: The companies plan combined research and operations after closing. Staffing decisions remain under review. No confirmed merger-related layoff count or competitor hiring surge was found.

Layer 9. Government pipeline: Required US competition reviews are a major approval condition. This is regulatory approval, not a government spending award.

Layer 10. Foreign warnings: The transaction and optical supply chain span the US and Asian manufacturing centres. No independent Chinese-, Japanese- or Thai-language supplier notice confirming customer switching was established.

Layer 11. Buyer behaviour: Lumentum's reported purchase commitments support commercial interest in optical products. Customers moving specifically because of the merger have not been identified.

Layer 12. Contradiction: The shares trade below the fixed exchange-ratio value despite sharply improving reported optical revenue. Merger risk, time and market expectations can explain the difference.

Layer 13. Missing activity: This research did not verify a rush of competitors receiving orders specifically because of the merger. That research limit is not proof that no switching occurred, but it prevents a claim of an established supplier-diversification boom.

Layer 14. Commercialisation: Lumentum's optical components and switching systems generate substantial revenue. Proposed future combined technologies must still be developed and qualified.

Layer 15. Competition: Coherent already has a large optical business. The proposed combined company might increase pressure on smaller rivals rather than help them.

Layer 16. Geography: US merger decisions could affect Asian optical manufacturing and global AI equipment buyers, including firms sourcing products through Thailand and China.

Layer 17. OTR history: OTR previously published research on moving optical links closer to AI processors. This signal tests a new financial development: a signed merger, its price gap and the possibility of rival customer wins. No completed historical outcome for this merger exists.

Layer 18. Awareness and pricing: The merger is widely reported. MRVL closed at US$141.20 and LITE at US$538.59 on 6 November. The deal gap is observable, not evidence of guaranteed undervaluation. Marvell's reported price-to-earnings ratio was approximately 47, reflecting substantial expectations.

Layer 19. Disproof: Approval failure, weak customer demand, excessive acquisition costs, falling component prices and competitors failing to win contracts would weaken the thesis.

Layer 20. Action trigger: Immediately: record the live merger spread, borrow costs and latest filing terms. By December 2026: seek evidence of newly awarded independent-supplier orders and review Marvell's next results, currently scheduled for 1 December. 2028: expected merger closing period. No leveraged position is justified solely by the price gap.